Darden’s LongHorn strength does not yet offset Olive Garden’s gap

Summary: Darden’s fiscal Q1 FY2027 release confirms positive comparable sales across every reported segment, but the consolidated 3.1% comp masks a split between Olive Garden at 1.1% and LongHorn at 6.2%. The FY27 EPS outlook was reaffirmed, not raised; at the $211.40 intraday reference, our transparent guide-multiple map has a flat base, a -16.0% adverse case, and -1.4% probability-weighted price value. Reject / no trade.

Research timestamp: September 25, 2026, 00:32 Singapore time (September 24, 2026, 16:32 UTC). U.S. market was in session. The latest completed regular-session close available at the run cutoff was September 23. A separately labeled September 24 intraday quote is used for post-release reference analysis only; it is not an executable entry.

Opportunity Ranking

Rank	Candidate	Direction	Mispricing	Evidence Freshness	Catalyst Window	Positioning	10/5 Status	Tradeability	Main Rejection Risk
1	Darden Restaurants (DRI)	Long screen	Strong LongHorn comps may be obscuring slow Olive Garden growth, but the unchanged guide and current multiple already price durable earnings	Issuer Q1 FY27 release dated Sep. 24; market reference at 12:17:39 p.m. EDT	Q1 price discovery is live; next quarter’s report date not confirmed in the reviewed issuer calendar	Direct current ownership, short, options, and flow evidence unavailable	Reject: flat base, -16.0% modeled bottom, zero positive base reward/risk	Liquid NYSE common; current spread, depth, venue quality, volume quality, and exit capacity unverified	Brand divergence may be structural; no evidence yet that Olive Garden can regain comp momentum or margins
2	TD SYNNEX (SNX)	Long screen	Record Q3 revenue/EPS and higher Q4 guide versus a sharp post-release decline	Issuer Q3 FY26 release dated Sep. 24; current market feed shows a large intraday fall	Same-day earnings reaction; next quarterly report	Direct current positioning unavailable	Reject: a deep drawdown alone does not bound downside; balance-sheet working capital and valuation need fuller reconciliation	NYSE common, but post-results price discovery and execution quality unverified	Q3 operating cash flow was negative $917M, receivables and inventories absorbed cash, and gross margin fell 61 bps
3	Costco Wholesale (COST)	Long screen	Strong membership-led sales versus premium valuation	August company sales release; Sep. 23 close; Q4 results scheduled after Sep. 24 close	Q4 FY26 result pending at the cutoff	Direct current positioning unavailable	Reject: no post-catalyst evidence or defensible bounded downside	Liquid Nasdaq common; execution evidence unavailable	About 45.5x trailing earnings leaves little valuation cushion if results or outlook disappoint

Selected opportunity: DRI, as the highest-information post-release screen, not as the best executable trade.

Why this one now: The new primary report supplies the brand-level comp and segment-profit bridge needed to test whether the weakness is isolated or whether the portfolio can absorb it. It updates the evidence boundary beyond Darden’s June FY26 results, which showed 4.6% consolidated Q4 comps and a new FY27 outlook.

What should surprise the reader: The better headline is real, but the consolidated number is not the whole story: Darden can grow sales and EPS while its largest brand barely grows same-store sales. The observed intraday recovery does not resolve that operating split.

Why This Is the Best Opportunity Right Now

The ranking is an information-value screen, not a claim that DRI has the best prospective return. DRI ranks first because the release shows what changed by brand and confirms the full-year EPS guide. SNX is a strong competing event, but its exceptional headline growth sits alongside material working-capital consumption, lower GAAP gross margin, and an approximately 12% intraday decline; a standalone rebound thesis would require a larger working-capital and valuation bridge. Costco has a useful same-day catalyst, but it had not reported by the cutoff and its roughly 45.5x trailing P/E leaves a difficult event-risk setup.

DRI’s long case has a coherent counterpoint: LongHorn’s 6.2% fiscal-calendar same-restaurant sales growth and 14.6% segment-profit increase show one major brand converting demand into profit, and every reported segment posted positive comps. Yet the price has not supplied a verified margin of safety. The long fails the Desk’s 10/5 screen before execution costs are considered.

Why This Can Move More Than 5% Soon

The Sep. 24 release is a dated information catalyst. Before it, a secondary market report described DRI down roughly 4% pre-market after Olive Garden comps came in at 1.1%; the issuer’s result also showed 6.2% LongHorn comps, 3.1% consolidated fiscal-calendar comps, EPS of $2.05, and an unchanged FY27 outlook. The price reference later recovered from a $199.51 intraday low to $211.40 at 12:17:39 p.m. EDT, while remaining 1.1% below the prior close. Those observations show a volatile reaction, not confirmed regular-session acceptance at the close.

A greater-than-5% move is plausible in either direction if the market treats Olive Garden’s slowdown as a temporary brand-level issue or as evidence that the company-wide guide is too demanding. That is a discovery condition, not evidence of a favorable long payoff. The September 24 regular-session close and next quarterly report are the cheapest tests of whether the opening reaction persists and whether the guide has operating support.

10/5 Asymmetry Gate

Test	Result from the September 24 intraday reference
Favorable base-case move	0.0%
Credible adverse scenario	-16.0%
Gross base reward / adverse risk	0:1 (base unchanged; no positive reward)
Costs	Not estimable without verified spread, depth, volume quality, and exit capacity; costs only worsen the case
Classification	Reject / no trade

The base does not approach +10%, the modeled adverse case breaches -5%, and the base reward-to-risk test fails. Because this is Reject before execution, missing execution evidence is not being used to manufacture a Watchlist.

What Should Surprise the Reader

Darden did not report a consolidated sales collapse. Q1 sales increased 5.1% to $3.200 billion, and adjusted diluted EPS from continuing operations was $2.05, up 4.1% against last year’s adjusted comparison. But Olive Garden generated $1.330 billion of sales with 1.1% same-restaurant growth; its segment profit rose only 1.2% to $270.8 million. LongHorn generated $861 million of sales, 6.2% same-restaurant growth, and segment profit of $154.6 million, up 14.6%. The distinction is between portfolio growth and broad-based organic strength.

The fiscal calendar comparison is also shifted by one week because FY26 had 53 weeks. Darden gives comparable-calendar comps of 1.0% at Olive Garden and 6.8% at LongHorn. That adjustment modestly lowers Olive Garden’s comp rather than explaining it away. The issuer’s own definition excludes Bahama Breeze from comps because its stores are expected to close or convert by Q4 FY27.

The Setup

Fact: Darden reaffirmed FY27 total sales of $13.60-$13.75 billion and diluted EPS from continuing operations of $11.10-$11.35. Q1 delivered $3.200 billion sales and $2.05 adjusted diluted EPS. The release records $222.3 million of repurchases during the quarter, leaving $1.3 billion of the authorization; authorization is not future guaranteed demand.

Inference: The portfolio is resilient enough to post positive comps and EPS growth, but the flagship Olive Garden is not currently carrying its share of the growth. A rising LongHorn contribution can conceal whether Olive Garden is stabilizing or losing relative relevance.

Unknown: The release alone does not establish current traffic versus check at each brand, how commodity inflation and pricing affected brand-level margins, or whether operating cash conversion supports the unchanged full-year guide. I do not have sufficient reliable data to quantify current direct positioning or intraday liquidity accurately.

The Market Price

DRI’s September 23 regular-session close was $213.69, up 0.07% on 1.85 million reported shares. The market-data feed’s September 24 observation was $211.40 at 12:17:39 p.m. EDT, down 1.07% from that close; the day’s high and low at that observation were $216.00 and $199.51, with 778,086 shares reported. This is an intraday context observation, not a close. The exact feed and observation are recorded in the signal.

At $211.40 and the $11.225 FY27 EPS guide midpoint, the equity trades at roughly 18.8x guided EPS. That is a price-to-guidance reference, not an enterprise-value calculation or intrinsic-value claim. The market is not pricing Olive Garden at zero; it still capitalizes the portfolio at a material multiple while asking the brand mix and consolidated guide to hold.

The Mispricing

The possible disagreement is whether the first-quarter brand split is a temporary mismatch or the emerging constraint on Darden’s mid-single-digit EPS ambitions. The positive case is that LongHorn has strong comp momentum, the other businesses are positive, EPS grew, and management reaffirmed its guide after seeing Q1. The skeptical case is that the largest segment’s same-store growth is barely positive, its segment profit margin edged down, and the release did not raise the full-year outlook.

There is no clean evidence that the market has underpriced a recovery. Third-party consensus before release was about $2.05 EPS and $3.2 billion revenue, both effectively met; a pre-release report cited analysts’ Olive Garden comp range of 1.3%-2.0%, making its 1.1% result a modest but identifiable shortfall. Neither the consensus miss nor the morning selloff proves a lasting valuation error. Subsequent regular-session recovery can also be a reversal in event flows rather than new fundamental information.

The Positioning

The quote and volume show a volatile session, not who owns the shares or who must trade them. Current short interest, borrow cost/utilization, options positioning, dealer exposure, fund flows, and ownership changes were not verified in this run. No squeeze or forced-flow thesis is assumed. The $222.3 million repurchase is issuer-reported completed activity for Q1; it supports actual demand in that period but does not create a floor or prove future purchases at these prices.

The Catalyst

Sep. 24 Q1 FY27 release, completed: compare fiscal-calendar and comparable-calendar brand comps with segment sales and profit; Darden reported 1.1%/1.0% Olive Garden comps and 6.2%/6.8% LongHorn comps.
Sep. 24 regular-session price discovery, still unresolved at cutoff: record the official close and compare it with the $213.69 prior close and $199.51 intraday low. One intraday observation cannot establish acceptance.
Next FY27 quarterly report, date not confirmed in reviewed issuer materials: test Olive Garden traffic/check, segment profit margin, food and labor cost trends, and whether the $11.10-$11.35 EPS guide remains intact. An earlier release or guide revision would accelerate the test; declining comps, lower profit conversion, or a cut would disconfirm the recovery interpretation.

Cheapest falsification test: the next filed quarterly release and call. If Olive Garden remains near flat while pricing/check props up sales, its segment margin slips, or management cuts FY27 EPS guidance, the “temporary mix” explanation fails. If its comps and profit conversion strengthen while LongHorn remains firm, the skeptical case weakens, but a fresh price and risk map would still be required.

The Payoff

This is a price-only sensitivity against the company’s FY27 per-share guide; no cash/debt/lease bridge or buyback-supported denominator forecast is added. The base assumes no multiple re-rating from the September 24 intraday quote, consistent with an unchanged outlook and insufficient evidence to underwrite a recovery. The top assumes 21x the guide high; the bottom assumes 16x the guide low. These multiples are explicit analyst assumptions, not observed fair-value bands or historical averages. The 20%/55%/25% probabilities are subjective judgments, not frequencies.

The strongest counterargument is that this disciplined model understates Darden’s ability to shift mix: LongHorn’s growth is faster and more profitable in dollars, the portfolio has pricing and brand diversity, and management reaffirmed the year. That case supports a positive operating view, but it does not make a flat-price base satisfy the Desk hurdle. The load-bearing assumption is that the current guide midpoint is a reasonable base and the market multiple does not expand absent proof that Olive Garden stabilizes.

Price Target and Probability Map

Scenario	Probability	Target / Level	Return / Payoff	Horizon	Conditions	Evidence Quality
Top Case	20%	$238.35	+12.8%	Through next FY27 quarterly report	21x $11.35 guide high; Olive Garden stabilizes and LongHorn momentum holds	Low: multiple is an assumption; operating trigger not yet demonstrated
Base Case	55%	$211.40	0.0%	Through next FY27 quarterly report	No multiple re-rating from the Sep. 24 intraday reference; guide midpoint remains broadly credible	Medium-low: guide reaffirmed, but the main brand split is unresolved
Bottom Case	25%	$177.60	-16.0%	Through next FY27 quarterly report	16x $11.10 guide low as Olive Garden weakness or cost pressure undermines guide confidence	Low: stress multiple is an explicit assumption, not a forecast
Invalidation	n/a	No numeric trigger	N/A	Next quarterly release or a material guide revision	Remove the temporary-mix interpretation if Olive Garden remains weak and guidance/cash conversion deteriorates; reassess if brand comps and profit conversion improve	Medium: observable primary tests; no single price threshold implied

Probability-weighted expected value: $208.34, or -1.4% versus the $211.40 reference, before costs: (20% × $238.35) + (55% × $211.40) + (25% × $177.60). This is a price-weighted scenario value, not enterprise value.

Current market level and timestamp: $211.40 at 2026-09-24 12:17:39 p.m. EDT / 16:17:39 UTC, regular-session intraday context.

Primary instrument: NYSE common stock, unlevered, reference analysis only.

10/5 favorable base move: 0.0%.

10/5 credible adverse move: 16.0%.

10/5 measurement basis: reference-only; latest completed regular close was $213.69 on September 23, 2026. The $211.40 observation is intraday and not executable.

10/5 status: Reject.

Confidence: Medium-low. The issuer’s results are clear; the forward multiple and scenario probabilities are judgment inputs, while positioning and execution evidence are missing.

The Kill Shot

The strongest counterparty case is that the stock’s initial pre-market decline overreacted to Olive Garden: LongHorn and the other segments posted positive comps, LongHorn profit grew faster than sales, EPS rose, and management reaffirmed the full-year range. If regular-session demand continues to recover and Olive Garden’s comp normalizes without sacrificing margin, the share price could re-rate.

That argument does not clear the bar. At the current reference, the modeled upside above 10% exists only in the lower-probability top case; the base is unchanged and the plausible adverse scenario exceeds the Desk’s 5% limit. The next quarter, not one volatile morning, must validate the brand-level repair.

What Could Go Wrong

Olive Garden’s traffic, customer frequency, or comparable-sales trend deteriorates further; pricing lifts checks but not guest demand.
Beef, seafood, labor, insurance, or other restaurant costs absorb sales growth and compress segment profit.
LongHorn comps slow from a high comparison base, leaving the portfolio without its current growth offset.
The FY27 EPS guide proves too ambitious; a later reduction would reset the earnings anchor as well as the multiple.
The measured premarket and intraday marks do not describe the executable market: spreads can widen, displayed liquidity can vanish, gaps and halts can prevent exits, and a long holding incurs market and opportunity costs.
Macro pressure on dining frequency or higher funding costs can depress restaurant valuations even if Darden meets nominal guidance.

What Would Prove This Wrong

The no-trade rejection would be too conservative if Olive Garden records improving comparable-calendar traffic and sales, restores or expands segment profit margin, LongHorn sustains positive traffic-led growth, and Darden’s next primary update supports or raises FY27 EPS without relying on one-off gains. That would justify rebuilding a new map from a fresh regular-session price; it would not retroactively make this reference map executable.

Risk Audit

The downside is not bounded by the $177.60 scenario. A guide cut, recession, brand deterioration, commodity spike, food-safety event, litigation, or broader multiple compression could move the shares lower. Intraday lows do not provide protection: gaps can bypass levels, and live spread, depth, venue, volume quality, and realistic exit liquidity remain unverified. The price-only map omits dividends and transaction costs; neither is large enough to cure the failed base/adverse geometry without verified inputs.

Best Trade Strategy

No trade. Entry price remains null. Revisit after the September 24 session is complete and the next quarterly report supplies a comparable traffic/check, segment margin, and guide-conversion bridge. Only then rebuild the scenarios and verify a fresh regular-session quote, spread, depth, venue quality, volume quality, and exit capacity. Common stock only if a future case independently passes the policy; no options, leverage, margin, market orders, or price-floor logic.

Sources

Darden Q1 FY2027 results and reaffirmed outlook, issuer release, Sep. 24, 2026. Primary source for comps, segment results, EPS, guidance, dividend, and completed repurchases.
Darden Q4 FY2026 results, SEC-filed issuer exhibit, June 25, 2026. Historical guide and prior-quarter reference only.
DRI quote and intraday market data, finance feed, accessed Sep. 24, 2026; latest observation used at 16:17:39 UTC. Market-data context only; no top-of-book or depth audit.
Darden Q1 earnings preview and estimates, Sep. 18, 2026, citing Refinitiv/S&P Global Market Intelligence for consensus. Secondary consensus snapshot only.
TD SYNNEX Q3 FY2026 results, company release carried by Business Wire, Sep. 24, 2026; candidate comparison only.
SNX quote and financial snapshot, accessed Sep. 24, 2026; current intraday quote was cross-checked through a separate market feed. Candidate comparison only.
Costco August sales results, issuer release, Sep. 2, 2026; candidate comparison only.
Costco Sep. 23 price and valuation snapshot, market data accessed Sep. 24, 2026; candidate comparison only.
Costco investor-relations events, checked Sep. 24, 2026; Q4 event timing comparison only.
Darden pre-market response, Investing.com, Sep. 24, 2026; secondary context for the opening reaction, not the underwriting source.

Research Quality Scorecard

Criterion	Score	Evidence and deduction
Market disagreement	4/5	Fresh split between high/low comp brands versus reaffirmed guide; no direct evidence of mispriced expectations
Evidence base	4/5	Fresh issuer release and regular-session market feed; cash-flow/call bridge not yet reconciled
Positioning and flows	2/5	Repurchase amount is known; direct holders, short/borrow, options, and flow evidence missing
Catalyst path	4/5	Q1 report is complete and testable; next report date not confirmed in reviewed IR materials
Payoff architecture	3/5	Guide-multiple sensitivity is transparent, but scenario multiples/probabilities are judgment inputs
Invalidation discipline	4/5	Brand comps, margin, and EPS-guide tests are observable; cash conversion remains to be checked
Differentiated insight	4/5	Separates consolidated comps from the economically important Olive Garden/LongHorn divergence
Client value	4/5	Explains why a volatile post-print session and a reaffirmed guide still do not establish 10/5
Total	29/40	Short note / no-trade screen; failed 10/5 economics override score

Bottom Line

Darden’s first quarter was not a collapse: revenue and EPS grew, LongHorn remained strong, and all segments posted positive comps. But the largest brand barely grew, the guide was not raised, and a transparent scenario map from the live intraday reference gives no positive base payoff against a credible double-digit downside. DRI is worth monitoring for brand-level stabilization, not publishing as a long opportunity that meets the Desk hurdle.

AI Illustration Prompt

Create a sober editorial illustration for The Mispricing Desk about Darden Restaurants (NYSE: DRI) immediately after its Q1 FY2027 report. Show a refined, realistic restaurant-company analysis room with two large brand ledgers: Olive Garden marked “COMPS 1.1% FISCAL / 1.0% COMPARABLE” and “SEGMENT PROFIT $270.8M / +1.2%”; LongHorn Steakhouse marked “COMPS 6.2% FISCAL / 6.8% COMPARABLE” and “SEGMENT PROFIT $154.6M / +14.6%.” Center a smaller portfolio board reading “TOTAL SALES $3.200B / +5.1%,” “BLENDED COMPS 3.1% FISCAL / 3.2% COMPARABLE,” “Q1 EPS $2.05 / +4.1%,” and “FY27 EPS GUIDE $11.10-$11.35 / REAFFIRMED, NOT RAISED.” Place a restrained market panel showing “SEP 23 CLOSE $213.69,” “SEP 24 INTRADAY $211.40 / 12:17:39 EDT,” “INTRADAY LOW $199.51,” and “ENTRY UNVERIFIED.” Include a three-branch paper valuation map with “TOP $238.35 / 20%,” “BASE $211.40 / 55%,” “BOTTOM $177.60 / 25%,” and a clear stamp “BASE +0% / ADVERSE -16% / REJECT.” Visually separate regular-session history, live intraday context, brand sales, segment profit, management outlook, and analyst assumptions. Use charcoal, cream paper, muted restaurant red, dark forest green, warm brass, and one quiet amber caution mark; documentary financial-journalism lighting, tactile menu paper and ledger textures. No generic candlestick chart, rockets, coins, invented logos, hype, or implied executable recommendation. Add a subtle readable “The Mispricing Desk” watermark. Wide 16:9 composition, premium magazine art direction, analytical and restrained.